Radiopharmaceuticals Market Demands: Clinical and Therapeutic Needs
The Radiopharmaceuticals Market demands are driven by the rising prevalence of cancer, cardiovascular diseases, and neurological disorders. Hospitals and diagnostic centers seek high-quality radiotracers for precise imaging and targeted therapy.
Demand for theranostic agents is increasing as they enable both diagnosis and treatment. Manufacturers focus on developing efficient, safe, and cost-effective radiopharmaceutical solutions to meet growing clinical requirements.
FAQQ1: What drives demand in the Radiopharmaceuticals Market?A1: Rising disease prevalence and the need for precise imaging and theranostic therapy.